Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

J10_CHEMGASRESP

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 J68
  • Hospital discharge: ICD-9 506
  • Hospital discharge: ICD-8 516[1-2]
  • Cause of death: ICD-10 J68
  • Cause of death: ICD-9 506
  • Cause of death: ICD-8 516[1-2]

2 out of 7 registries used, show all original rules.

316

4. Check minimum number of events

None

316

5. Include endpoints

None

316

6. Filter based on genotype QC (FinnGen only)

316

Control definitions (FinnGen only)

Control exclude
J10_EXTERLUNG

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J60-J70
Name in latin
Morbositates respiratoriae ex inhalatione chemicalium, gasorum, fumorum et vaporum

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3900 1869 1984
Only index persons 2958 1403 1555
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.06
Only index persons 0.06 0.05 0.06
Median age at first event (years)
Whole population 46.70 48.34 45.06
Only index persons 43.67 45.69 41.84

-FinnGen-

Key figures

All Female Male
Number of individuals 316 124 192
Unadjusted period prevalence (%) 0.07 0.04 0.08
Median age at first event (years) 44.73 44.13 45.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
284
Matched controls
2838
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
51610
ICD-8 Finland
Other pneumoconiosis and related diseases, Due to inhalation of other dust
+∞
85.9
78
*
J68.0
ICD-10 Finland
Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours
+∞
60.6
56
*
J68.3
ICD-10 Finland
Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours
+∞
55.0
51
*
J68.9
ICD-10 Finland
Unspecified respiratory condition due to chemicals, gases, fumes and vapours
+∞
39.5
37
*
51620
ICD-8 Finland
Other pneumoconiosis and related diseases, Due to inhalation of fumes
+∞
26.5
25
*
4950A
ICD-9 Finland
Extrinsic allergic alveolitis, Farmers' lung
+∞
21.1
20
*
J68.2
ICD-10 Finland
Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified
+∞
14.7
14
*
J68.4
ICD-10 Finland
Chronic respiratory conditions due to chemicals, gases, fumes and vapours
+∞
14.7
14
*
J67.0
ICD-10 Finland
Farmer lung
+∞
13.6
13
*
R03AC02
ATC
salbutamol; inhalant
2.5
12.0
166
1034
R06.0
ICD-10 Finland
Dyspnoea
2.6
10.3
94
459
J45.9
ICD-10 Finland
Asthma, unspecified
2.8
9.6
70
299
J68.1
ICD-10 Finland
Pulmonary oedema due to chemicals, gases, fumes and vapours
+∞
8.4
8
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.5
8.2
70
327
R03BA02
ATC
budesonide; inhalant
2.6
7.9
63
280
H02AB06
ATC
prednisolone; systemic
2.0
7.4
139
919
5060A
ICD-9 Finland
Respiratory conditions due to chemical fumes and vapours, Bronchitis and pneumonitis due to fumes and vapours
+∞
7.3
7
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.1
7.0
39
139
R03BA05
ATC
fluticasone; inhalant
2.4
6.5
55
255
T59.8
ICD-10 Finland
Toxic effect: Other specified gases, fumes and vapours
+∞
6.3
6
*
5062A
ICD-9 Finland
Respiratory conditions due to chemical fumes and vapours, Upper respiratory inflammation due to fumes and vapours
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016502) Oxygen saturation in Arterial blood
56
270
2.31
6.78
6.6
9.3
%
95.3
95.7
0.25
51
262
(3022806) Fractional oxyhemoglobin in Capillary blood
15
32
4.87
6.76
1.5
1.8
%
90.2
90.2
0.00
15
32
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
89
530
1.95
6.17
1.8
1.7
mg/l
1.4
1.3
0.11
68
418
(40767503) Oxygen content in Capillary blood by calculation
19
55
3.61
5.83
2.7
2.3
%
17.0
15.3
—
10
29
(3027315) Oxygen [Partial pressure] in Blood
18
52
3.61
5.54
3.9
3.7
kpa
8.5
8.3
0.23
18
52
(3013290) Carbon dioxide [Partial pressure] in Blood
18
52
3.61
5.54
3.9
3.7
kpa
4.9
5.0
0.13
18
52
(3028271) Lactate [Moles/volume] in Capillary blood
16
43
3.87
5.44
1.8
1.8
mmol/l
1.6
1.6
0.01
16
43
(3003396) Base excess in Arterial blood by calculation
55
296
2.04
5.01
7.0
8.8
mmol/l
1.6
1.0
0.37
40
240
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
32
145
2.34
4.45
7.5
6.5
mmol/l
24.9
24.6
0.13
32
145
(3013826) Glucose [Moles/volume] in Serum or Plasma
186
1471
1.64
4.42
5.5
5.2
mmol/l
6.7
6.8
0.36
172
1378
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
47
253
2.01
4.27
3.5
3.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
32
3.86
4.12
2.1
3.1
—
—
—
0
0
(4062490)
10
23
4.46
4.12
1.3
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
36
180
2.13
3.98
4.4
6.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
9
17
5.42
3.53
4.7
2.1
%
13.1
13.3
—
9
17
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
135
1033
1.54
3.39
4.7
3.9
ng/l
33.4
47.9
0.78
103
730
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
65
418
1.70
3.35
2.1
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
79
539
1.62
3.24
5.8
4.3
kg/l
1.0
1.0
—
10
68
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
31
166
1.96
2.88
3.7
3.1
mmol/l
1.8
1.7
0.05
21
119
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
84
2.34
2.83
1.8
2.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
12
42
2.93
2.78
1.4
2.0
g/l
0.3
1.0
—
7
33
(3013115) Eosinophils [#/volume] in Blood
155
1257
1.46
2.77
6.5
6.1
e9/l
0.2
0.2
0.09
139
1126
(3009343) pH of Capillary blood
32
176
1.91
2.76
3.7
3.0
ph
7.4
7.4
—
8
24
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
49
2.72
2.65
3.9
2.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
153
1247
1.44
2.62
6.2
5.9
e9/l
1.8
1.8
0.05
137
1118
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
173
1.88
2.57
1.5
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
137
1101
1.43
2.50
4.0
5.1
g/l
35.4
35.6
0.15
125
1033
(3032080) INR in Blood by Coagulation assay
128
1016
1.44
2.50
17.0
8.9
inr
1.4
1.2
1.29
48
306
(3006315) Basophils [#/volume] in Blood
149
1219
1.42
2.45
6.3
5.8
e9/l
0.0
0.0
0.07
133
1079
(3022217) INR in Platelet poor plasma by Coagulation assay
52
344
1.61
2.40
28.0
22.5
inr
1.3
1.3
—
5
53
(3020891) Body temperature
21
106
2.05
2.31
6.1
4.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
122
971
1.42
2.31
5.2
4.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
31
182
1.78
2.21
3.6
4.5
%
1.8
0.4
—
9
49
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
42
2.68
2.21
1.7
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
61
2.36
2.18
2.5
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
14
4.35
2.16
1.0
1.0
—
—
—
0
0
(4027681)
6
14
4.35
2.16
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
141
1162
1.39
2.14
6.5
5.9
%
25.3
26.7
0.93
136
1093
(3013650) Neutrophils [#/volume] in Blood by Automated count
167
1418
1.38
2.10
8.7
9.6
e9/l
4.3
4.2
0.24
146
1262
(3001604) Monocytes [#/volume] in Blood
146
1216
1.37
2.06
6.5
5.8
e9/l
0.6
0.6
0.39
131
1070
(3028707) Methadone [Presence] in Urine by Screen method
10
38
2.68
2.03
2.5
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
33
203
1.70
2.02
3.8
4.5
%
1.6
0.9
0.43
11
70
(4034850)
16
77
2.14
2.00
13.2
9.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
85
650
1.42
1.97
6.1
4.1
estimate
0.0
0.0
0.50
27
214
(3035350) Ketones [Presence] in Urine by Test strip
146
1222
1.36
1.97
5.0
3.8
estimate
0.0
0.0
0.00
27
228
(3021440) Promyelocytes/100 leukocytes in Blood
31
189
1.71
1.96
3.5
4.6
%
0.2
0.1
—
10
62
(3019069) Monocytes/100 leukocytes in Blood
137
1139
1.36
1.92
7.2
6.2
%
8.7
8.8
0.10
132
1078
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
65
2.21
1.91
1.5
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
74
555
1.44
1.91
4.2
4.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
59
2.26
1.87
3.5
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
136
1135
1.35
1.84
6.6
5.9
%
3.0
2.9
0.17
131
1069
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
98
777
1.38
1.83
2.8
3.3
ng/l
1950.3
1414.4
0.54
86
660
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
12
4.21
1.83
1.8
1.3
%
75.2
68.3
—
5
7
(3042631) Mycobacterium sp identified in Specimen
9
35
2.62
1.81
2.8
2.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
267
2481
1.49
1.81
17.6
15.0
mg/l
23.4
23.4
0.00
224
1974
(3001893) Eosinophils/100 leukocytes in Pleural fluid
5
13
3.89
1.72
1.8
1.3
%
0.6
1.3
—
5
8
(3021601) Nitrite [Presence] in Urine by Test strip
145
1234
1.32
1.68
6.2
5.2
estimate
0.0
0.0
0.00
28
225
(3011397) Hemoglobin [Presence] in Urine by Test strip
74
569
1.39
1.65
5.3
3.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
33
215
1.60
1.65
8.9
8.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
29
183
1.64
1.64
3.7
4.7
%
0.1
0.2
—
8
55
(3009261) Glucose [Presence] in Urine by Test strip
146
1249
1.31
1.61
5.0
3.8
estimate
0.0
0.0
0.00
25
213
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
71
2.02
1.56
2.1
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
210
1894
1.32
1.56
7.0
7.9
u/l
75.3
78.6
0.73
198
1769
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
93
1.88
1.55
2.0
2.1
—
—
—
0
0
(44790049)
8
33
2.46
1.55
1.3
1.6
—
—
—
0
0
(44790048)
8
33
2.46
1.55
1.3
1.6
—
—
—
0
0
(44790047)
8
33
2.46
1.55
1.3
1.6
—
—
—
0
0
(44806118)
8
33
2.46
1.55
1.3
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
95
769
1.34
1.53
2.9
2.6
u/l
58.3
57.5
0.07
88
722
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
15
3.37
1.53
1.6
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
15
3.37
1.53
1.6
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
15
79
1.94
1.52
2.5
5.3
mg/l
56.4
39.9
—
9
63
(3034860) Kappa light chains.free [Mass/volume] in Serum
15
79
1.94
1.52
2.5
5.3
mg/l
41.4
158.4
—
9
63
(40760888) Immunoglobulin light chains.free panel - Serum
12
58
2.11
1.51
2.7
6.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
65
2.04
1.51
1.5
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
37
2.47
1.49
1.8
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
37
2.47
1.49
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
95
772
1.33
1.49
3.2
3.0
mmol/l
7.8
8.1
0.21
82
641
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
88
1.86
1.44
2.2
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
40
2.29
1.41
1.8
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
53
2.11
1.40
1.7
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
89
724
1.32
1.38
5.2
4.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
43
310
1.45
1.38
1.3
1.3
titre
536.0
596.5
—
10
68
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
109
912
1.30
1.37
4.0
3.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
23
2.64
1.37
1.2
1.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
37
0.00
1.35
0.0
4.6
—
350.1
—
0
32
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
185
1.56
1.34
2.6
3.2
ml/min/173m2
73.8
63.5
0.45
12
90
(3006184) Hemoglobin [Mass/volume] in Capillary blood
12
61
2.01
1.34
2.7
1.9
g/l
134.1
125.7
0.60
12
44
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
17
98
1.78
1.34
4.0
3.8
mmol/l
24.7
24.9
0.14
17
93
(42870588) Differential panel, method unspecified - Blood
97
802
1.30
1.33
6.1
5.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
33
227
1.51
1.33
1.9
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
148
1293
1.27
1.32
5.5
6.8
umol/l
11.3
11.6
0.14
138
1229
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
24
2.53
1.31
1.0
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
130
1119
1.27
1.30
6.5
6.4
mmol/l
1.2
1.2
1.13
119
1010
(3022313) Gas panel - Capillary blood
20
123
1.67
1.27
4.1
3.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
298
1.43
1.27
2.1
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
60
466
1.35
1.26
1.4
1.4
g/l
2.8
2.6
0.23
40
304
(3025941) Bacteria identified in Stool by Culture
7
141
0.49
1.24
1.1
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
93
1.76
1.23
2.0
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
196
1780
1.27
1.23
3.9
3.8
pmol/l
15.1
14.9
0.48
173
1596
(40761535) Cells panel - Urine sediment
30
206
1.50
1.23
4.4
3.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
50
379
1.38
1.22
1.2
1.3
iu/ml
18.7
34.3
1.16
16
125
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
46
344
1.39
1.22
2.7
2.2
%
21.5
22.7
0.29
36
298
(3045788) Cell count panel - Pleural fluid
5
19
2.66
1.22
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
133
1.62
1.21
10.0
13.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
140
1226
1.25
1.19
7.0
7.2
mmol/l
1.2
1.2
0.47
118
1036
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
6
26
2.33
1.19
1.2
1.3
u/l
275.0
287.7
—
6
26
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
50
2.03
1.17
2.9
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
89
739
1.28
1.17
2.7
3.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
33
234
1.46
1.17
7.2
6.6
mmol/l
1.5
1.4
0.29
33
225
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
199
1820
1.25
1.13
4.5
4.0
mm/h
12.0
12.3
0.10
187
1678
(3018418) pH of Serum or Plasma
89
743
1.28
1.12
4.1
4.3
ph
7.4
7.4
0.38
26
130
(4010399)
26
177
1.51
1.12
1.1
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
115
992
1.25
1.10
3.1
2.6
ug/l
165.7
136.4
0.79
104
914
(3041096) Erythrocytes [Presence] in Urine by Automated
83
689
1.28
1.09
3.7
3.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
21
2.40
1.09
1.0
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
186
1695
1.24
1.07
5.6
4.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
90
1.70
1.06
2.1
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
98
1.67
1.05
2.0
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
65
526
1.30
1.04
2.9
2.6
e6/l
3.0
5.7
0.96
57
460
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
66
537
1.29
1.02
1.8
1.8
pmol/l
471.3
8734056.5
0.50
56
458
(3027008) Opiates [Presence] in Urine
16
99
1.65
1.02
2.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
99
1.65
1.02
2.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
85
714
1.26
1.02
3.2
3.2
mg/l
40.6
226.3
0.85
60
472
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
62
501
1.30
1.01
1.2
1.2
u/ml
4.0
1.0
0.41
14
145
(3027944) Amphetamines [Presence] in Urine
16
100
1.63
0.98
2.1
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.2
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.2
2.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
5
23
2.19
0.98
1.4
1.3
e6/l
4117.0
1874.1
—
5
16
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.2
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
23
2.19
0.98
6.6
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
141
1.52
0.97
1.0
1.2
iu/ml
225.1
113.1
—
8
55
(46235355) HIV 1 and 2 tests - Meaningful Use set
51
404
1.31
0.96
1.5
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
37
1.91
0.94
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
35
263
1.37
0.93
1.4
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
26
185
1.44
0.93
2.8
3.6
g/l
65.3
66.7
0.45
26
171
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
203
1.42
0.91
6.0
3.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
42
1.93
0.89
1.5
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
79
669
1.24
0.88
2.7
2.9
umol/l
362.0
6652.2
2.62
67
577
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
71
596
1.25
0.86
2.5
2.1
mg/l
3.0
3.0
0.03
62
517
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
47
1.72
0.81
1.6
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
33
252
1.35
0.81
1.9
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
119
1060
1.20
0.80
14.0
10.3
e9/l
0.0
0.0
0.48
103
881
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
41
324
1.31
0.80
1.5
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
124
1109
1.19
0.80
4.7
4.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
33
1.83
0.79
2.0
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
74
1.65
0.79
1.3
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
298
1.31
0.78
2.2
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
48
389
1.28
0.78
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
88
764
1.21
0.77
4.2
3.9
mg/mmol
8.9
7.9
0.07
63
502
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
88
764
1.21
0.77
2.4
2.1
u/l
126.9
230.6
3.04
83
725
(3024354) Oxygen [Partial pressure] in Venous blood
28
211
1.36
0.75
3.3
2.6
kpa
4.4
4.4
0.00
28
201
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
111
988
1.19
0.75
2.2
2.0
pmol/l
91.0
93.4
0.20
66
541
(3013512) EKG study
81
701
1.21
0.74
4.8
4.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
25
2.02
0.73
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
39
1.81
0.73
1.7
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
40
1.77
0.71
1.7
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
26
1.94
0.71
2.0
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
89
781
1.19
0.70
3.6
3.3
e6/l
52.0
136.3
0.49
73
596
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
42
1.68
0.69
6.6
2.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
42
1.68
0.69
1.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
27
1.87
0.68
1.0
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
80
698
1.20
0.67
3.6
3.1
e6/l
0.3
0.5
0.43
64
516
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
28
1.80
0.66
2.2
2.2
pg
32.6
33.1
—
5
28
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
118
1067
1.17
0.65
4.6
4.6
ug/l
3.2
2.5
0.28
107
971
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
243
2325
1.20
0.65
5.5
5.8
mmol/mol
41.2
40.2
0.73
226
2181
(3021447) Carbon dioxide [Partial pressure] in Venous blood
32
254
1.29
0.62
3.8
3.5
kpa
5.9
5.7
0.45
32
246
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
63
1.61
0.62
1.9
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
30
1.68
0.61
1.2
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
57
486
1.21
0.61
4.4
3.9
ng/l
93.5
173.6
0.57
40
393
(3023520) Reticulocytes [#/volume] in Blood
28
219
1.31
0.61
2.3
2.9
e9/l
75.8
70.6
0.17
20
174
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
80
1.52
0.60
1.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
55
641
0.83
0.60
1.7
1.7
mmol/l
2.0
1.4
0.68
39
530
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
52
1.55
0.60
1.4
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
28
220
1.30
0.59
3.4
4.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
42
348
1.24
0.59
1.3
1.2
u/ml
1.2
6.8
0.96
14
129
(40768795) Lymph node Pathology biopsy report
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
263
2542
1.21
0.58
20.9
17.7
mmol/l
4.0
4.0
0.45
258
2472
(36304419) Bacteria [Presence] in Urine
76
670
1.18
0.57
3.6
3.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
87
0.57
0.57
5.4
4.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
34
276
1.26
0.57
2.2
2.4
ug/g
110.9
149.0
0.41
21
222
(3018095) Leukocytes [#/volume] in Urine
98
883
1.16
0.56
4.0
3.9
e6/l
89.8
73.2
0.10
77
636
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
35
424
0.80
0.56
3.7
3.0
e6/l
3.1
1.6
0.57
21
242
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
230
2202
1.16
0.55
4.6
4.5
mu/l
2.1
1.9
0.68
211
2002
(3050129) First trimester maternal screen panel - Serum or Plasma
6
38
1.59
0.54
1.7
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
61
1.49
0.54
1.9
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
74
1.50
0.54
1.5
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
38
315
1.23
0.54
1.3
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
39
1.55
0.53
1.8
2.8
e9/l
3.8
4.8
—
6
39
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
39
1.55
0.53
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
66
1.53
0.53
2.0
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
186
1758
1.14
0.53
4.8
4.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
40
1.51
0.52
2.0
3.4
%
58.7
58.8
—
6
40
(3004588) Protein electrophoresis panel - Serum or Plasma
21
162
1.32
0.51
2.7
3.1
—
—
—
0
0
(3002256) Pathology report gross observation
36
299
1.23
0.50
1.6
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
47
402
1.20
0.50
2.2
1.9
s
29.3
29.8
0.30
47
390
(3027945) Reticulocytes/100 erythrocytes in Blood
36
300
1.23
0.49
2.4
2.8
%
2.1
1.8
0.41
30
277
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
22
174
1.28
0.46
2.6
3.5
ng/l
75.1
79.6
0.14
15
160
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
83
0.60
0.46
1.4
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
57
501
1.17
0.45
3.4
2.9
mosm/kgh2o
499.6
562.1
1.27
46
424
(3015377) Calcium [Moles/volume] in Serum or Plasma
90
819
1.14
0.45
2.5
3.4
mmol/l
2.4
2.3
0.28
81
721
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
95
1.38
0.44
1.5
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
32
1.57
0.42
1.6
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
33
1.52
0.41
1.4
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
554.4
—
0
7
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
255.0
—
0
7
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
34.7
—
0
6
(3017704) Immunofixation for Urine
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
7.6
—
0.6
—
0
15
(3019309) Folate [Moles/volume] in Red Blood Cells
56
497
1.15
0.40
2.1
1.7
nmol/l
1142.0
1164.3
0.08
47
388
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
13
97
1.35
0.40
3.2
2.3
u/l
34.9
39.1
0.44
13
88
(3016038) Potassium [Moles/volume] in Urine
0
18
0.00
0.40
0.0
1.0
—
35.1
—
0
18
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
3.8
—
104.7
—
0
18
(3015183) Erythrocyte sedimentation rate
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
71
1.42
0.39
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
33
280
1.20
0.39
1.5
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
2.0
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
66
594
1.14
0.39
6.4
7.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
80
1.39
0.39
8.7
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
290
1.19
0.39
9.4
8.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
220
2274
0.89
0.38
16.4
15.4
%
40.0
40.5
0.33
152
1642
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
143
1.27
0.38
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
63
568
1.14
0.36
2.7
2.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
5
79
0.63
0.36
3.6
1.8
mg/l
1.9
4.1
—
5
56
(3019230) Fractional oxyhemoglobin in Venous blood
6
46
1.31
0.33
1.2
1.8
%
72.3
64.0
—
6
46
(3021960) Folate [Moles/volume] in Serum or Plasma
66
602
1.12
0.32
1.6
1.6
nmol/l
17.5
20.3
0.72
59
515
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
19
156
1.23
0.31
2.1
2.5
—
7.9
—
0
8
(21494755) Public health laboratory ask at order entry panel
21
249
0.83
0.30
1.3
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
55
1.28
0.30
1.0
1.1
—
3.7
—
0
6
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
56
1.26
0.29
1.6
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
20
167
1.21
0.29
1.3
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
97
913
1.09
0.27
2.9
2.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
67
1.20
0.26
1.9
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
58
630
0.90
0.26
2.9
2.9
ug/l
0.7
0.8
0.29
37
393
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
142
1.21
0.25
1.1
1.3
—
21.4
—
0
10
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
244
0.85
0.25
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
68
632
1.10
0.24
1.4
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
81
0.74
0.24
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
83
0.72
0.24
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
83
0.72
0.24
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
106
1.24
0.23
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
29
257
1.14
0.23
3.9
4.8
ug/l
20.9
24.5
0.06
24
211
(3002523) Influenza virus A Ag [Presence] in Specimen
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
11
0.00
0.21
0.0
15.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.9
—
57.6
—
0
11
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
10
0.00
0.21
0.0
1.1
—
3.2
—
0
10
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
26
230
1.14
0.21
2.3
2.4
g/l
0.2
0.2
0.48
26
216
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
41
448
0.90
0.21
3.1
2.8
e6/l
1.1
0.9
0.22
26
263
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
5.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
53
1.13
0.19
2.0
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
53
1.13
0.19
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
153
0.84
0.18
1.2
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
62
1.13
0.17
1.4
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
224
0.89
0.16
1.3
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
28
255
1.11
0.15
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
83
1.21
0.15
1.3
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
78
1.16
0.15
1.7
3.1
g/l
34.5
37.8
—
9
69
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
239
2354
1.06
0.15
3.8
4.0
mmol/l
1.4
1.3
0.64
218
2165
(36660697) Celiac disease serology panel - Serum
18
160
1.13
0.14
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
268
2652
1.07
0.13
10.7
10.5
u/l
28.5
27.8
0.29
257
2568
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
152
1.13
0.12
1.6
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
33
308
1.08
0.12
2.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
221
1.09
0.11
1.5
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
15
134
1.13
0.11
2.1
3.4
pmol/l
4.5
4.5
0.02
15
118
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
125
0.88
0.10
2.9
2.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
55
1.09
0.09
1.0
1.2
—
0.9
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
55
1.09
0.09
1.7
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
245
2427
1.04
0.08
4.2
4.3
mmol/l
1.4
1.4
0.66
223
2235
(40768800) Prostate Pathology biopsy report
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
61
0.82
0.08
1.2
3.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
60
0.83
0.08
1.2
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
18
166
1.09
0.08
3.6
2.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
70
0.85
0.07
1.5
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
73
0.82
0.07
2.3
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
79
771
1.03
0.06
2.6
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
105
0.85
0.06
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
22
233
0.94
0.06
2.5
2.5
u/l
32.6
30.8
0.23
17
197
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
154
1522
1.02
0.05
3.1
2.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
120
0.91
0.05
1.3
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
233
2315
1.02
0.04
15.3
14.0
ml/min/173m2
80.8
80.2
0.15
196
1905
(40761511) CBC panel - Blood by Automated count
259
2577
1.03
0.04
16.6
14.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
86
872
0.98
0.03
5.1
4.0
%
21.0
21.6
0.19
44
394
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
239
0.96
0.03
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
138
0.94
0.02
3.9
4.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
245
2440
1.02
0.02
4.3
4.4
mmol/l
4.6
4.5
0.05
226
2261
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
240
2390
1.02
0.02
4.8
4.5
mmol/l
6.2
6.0
0.65
221
2180
(3000494) Fungus identified in Specimen by Culture
31
304
1.02
0.00
1.2
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
108
1.02
0.00
2.3
2.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
13
128
1.02
0.00
3.2
3.2
mmol/l
23.5
24.2
0.49
13
117
(3010813) Leukocytes [#/volume] in Blood
276
2758
1.01
0.00
26.1
21.6
e9/l
6.7
6.7
0.05
270
2688
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
98
978
1.00
0.00
2.3
2.3
nmol/l
73.9
75.1
0.16
88
868
(3042936) Bacteria identified in Isolate by Culture
39
389
1.00
0.00
1.8
2.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
48
481
1.00
0.00
3.0
3.1
mmol/l
2.5
2.4
0.57
39
426
(40768804) Tissue Pathology biopsy report
94
939
1.00
0.00
2.4
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
170
1701
1.00
0.00
3.5
3.2
u/l
58.6
50.2
0.47
156
1610
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
157
1.02
0.00
2.2
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
276
2757
1.01
0.00
26.0
21.5
e12/l
4.6
4.5
0.05
269
2687
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
249
2493
0.99
0.00
4.7
4.9
mmol/l
2.7
2.7
0.01
227
2302
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
185
1.03
0.00
1.4
1.5
—
—
—
0
0
(4035726)
20
205
0.97
0.00
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
275
2754
0.99
0.00
26.0
21.5
e9/l
242.0
242.3
0.02
270
2690
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
1.1
—
0
6
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
12.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.5
—
5.0
—
0
6
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.2
—
0
6
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
129.4
—
0
7
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
22.5
—
0
6
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
7
0.00
0.00
0.0
3.6
—
8165.6
—
0
7
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.3
—
0
6
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
36.0
—
0
6
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
94
0.96
0.00
1.9
1.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
12.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
12.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
71
0.99
0.00
2.7
3.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
49
1.02
0.00
1.0
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
98
0.92
0.00
1.7
2.8
g/l
7.3
7.3
—
9
76
(3034426) Prothrombin time (PT)
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
21.5
—
0
8
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
91
0.99
0.00
1.7
2.9
g/l
3.4
3.0
—
9
75
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
59
0.85
0.00
1.6
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
98
0.92
0.00
1.3
2.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
9
0.00
0.00
0.0
4.6
—
51.8
—
0
9
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
159.2
—
0
5
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
98
0.92
0.00
1.7
2.8
g/l
3.3
3.6
—
9
73
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
91
0.99
0.00
1.7
2.9
g/l
9.7
10.5
—
9
81
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
98
0.92
0.00
1.7
2.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
123.2
—
0
9
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036489) Thrombin time
8
86
0.93
0.00
1.9
2.0
s
21.6
22.1
—
8
78
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint J10_CHEMGASRESP and mortality.

Females

Parameter HR [95% CI] p-value
J10_CHEMGASRESP 2.547 [1.64, 3.96] < 0.001
Birth year 0.991 [0.98, 1.0] 0.057

During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 394 females with J10_CHEMGASRESP died.

Males

Parameter HR [95% CI] p-value
J10_CHEMGASRESP 2.008 [1.58, 2.55] < 0.001
Birth year 0.992 [0.98, 1.0] 0.069

During the follow-up period (1.1.1998 — 31.12.2019), 143 out of 908 males with J10_CHEMGASRESP died.

Mortality risk

Mortality risk for people of age

years, who have J10_CHEMGASRESP.

N-year risk Females Males
1 0.175% 0.377%
5 1.164% 2.493%
10 3.067% 6.557%
15 6.139% 12.833%
20 10.725% 21.588%

Relationships between endpoints

Index endpoint: J10_CHEMGASRESP – Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data